Form D · Other
Ault Life Sciences, Inc.
Newport Beach, CA · CIK 0001813309
Offering snapshot reported Jun 15, 2020 · SEC filing
- Reported sold
- Yet to sell Offering amount: $100M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 15, 2020 | Initial | $72,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-368907
Source: Form D, filed Jun 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Milton C. Ault | Director, Executive |
| Kenneth S. Cragun | Executive |
| William B. Horne | Director, Executive |
| Brittany Nerpin | Executive |
| Henry W. Nisser | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
201 Shipyard Way Suite E
Newport Beach, CA, 92663
Newport Beach, CA, 92663